- Open
- 246.00
- High
- 246.00
- Low
- 245.50
- Close
- 245.50
- Change
- -0.50 (-0.20%)
- Volume
- 12,159
| 10 Sept 2026 | 07:00:01 | Holding(s) in Company |
| 7 Sept 2026 | 15:20:00 | Pentwater Capital Management LP - Form 8.3 - Spire Healthcare Group Plc |
| 7 Sept 2026 | 07:00:05 | Board and Management Changes |
| 4 Sept 2026 | 16:48:31 | Further extension of the PUSU Deadline |
| 6 May 2026 | Spire Healthcare Plc annual reports and accounts | |
| 2 Jul 2025 | Spire Healthcare Plc annual reports and accounts | |
| 1 May 2024 | Spire Healthcare Plc Annual Report and Accounts |
Spire Healthcare Group PLC operates a network of 38 private hospitals and nearly 100 clinics across England, Wales, and Scotland, providing a range of healthcare services. The company offers treatments for private patients, NHS services, and employer-funded health support, including diagnostics, surgery, mental health care, and physiotherapy. Spire generates revenue through self-pay patients, private medical insurers, and contracts with the NHS, focusing on delivering personalized care and expanding its healthcare offerings.
| 10 Sept 2026 | 07:00:01 | Holding(s) in Company |
| 7 Sept 2026 | 15:20:00 | Pentwater Capital Management LP - Form 8.3 - Spire Healthcare Group Plc |
| 7 Sept 2026 | 07:00:05 | Board and Management Changes |
| 4 Sept 2026 | 16:48:31 | Further extension of the PUSU Deadline |
| 6 May 2026 | Spire Healthcare Plc annual reports and accounts | |
| 2 Jul 2025 | Spire Healthcare Plc annual reports and accounts | |
| 1 May 2024 | Spire Healthcare Plc Annual Report and Accounts |
Spire Healthcare Group PLC operates a network of 38 private hospitals and nearly 100 clinics across England, Wales, and Scotland, providing a range of healthcare services. The company offers treatments for private patients, NHS services, and employer-funded health support, including diagnostics, surgery, mental health care, and physiotherapy. Spire generates revenue through self-pay patients, private medical insurers, and contracts with the NHS, focusing on delivering personalized care and expanding its healthcare offerings.
| 4 Sept 2026 | 15:20:00 | Pentwater Capital Management LP - Form 8.3 - Spire Healthcare Group PLC |
| 7 Sept 2026 |
| Spire Healthcare agrees to be taken private in £1bn takeover deal |
| 7 Sept 2026 | Spire Healthcare agrees to £1.03bn takeover |
| 7 Sept 2026 | AstraZeneca's breast cancer drug gets accelerated US approval, Spire Healthcare agrees to £1.03bn takeover bid |
| 7 Sept 2026 | Spire Healthcare agrees £1.03 billion takeover as management reshuffles |
| 6 Sept 2026 | Spire Healthcare overhauls board amid £1bn private takeover |
| 2 Sept 2026 | Spire Healthcare buyer squares Circle as £1bn takeover looms |
| 4 Sept 2026 | 15:20:00 | Pentwater Capital Management LP - Form 8.3 - Spire Healthcare Group PLC |
| 7 Sept 2026 |
| Spire Healthcare agrees to be taken private in £1bn takeover deal |
| 7 Sept 2026 | Spire Healthcare agrees to £1.03bn takeover |
| 7 Sept 2026 | AstraZeneca's breast cancer drug gets accelerated US approval, Spire Healthcare agrees to £1.03bn takeover bid |
| 7 Sept 2026 | Spire Healthcare agrees £1.03 billion takeover as management reshuffles |
| 6 Sept 2026 | Spire Healthcare overhauls board amid £1bn private takeover |
| 2 Sept 2026 | Spire Healthcare buyer squares Circle as £1bn takeover looms |
| Issuer | Mkt cap | 1Y |
|---|---|---|
SPISpire Healthcare Group PLC | £990m | +0.2% |
| £313m | +0.0% | |
| £277m | -0.1% | |
| £196m | +0.1% | |
| £28m | +0.9% | |
| £13m | +1.8% |
| Issuer | Mkt cap | 1Y |
|---|---|---|
SPISpire Healthcare Group PLC | £990m | +0.2% |
| £313m | +0.0% | |
| £277m | -0.1% | |
| £196m | +0.1% | |
| £28m | +0.9% | |
| £13m | +1.8% |